Secreted β3-integrin enhances natural killer cell activity against acute myeloid leukemia cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Skaik, Younis ^a   Vahlsing, Stefanie ^a   Goudeva, Lilia ^a   Eiz Vesper, Britta ^a   Battermann, Anja ^a   Blasczyk, Rainer ^a   Figueiredo, Constança ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 15; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; GRANZYME; ISOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD SAMPLING; CELL ACTIVITY; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXICITY ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOMODULATION; LEUKEMIA CELL; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ACUTE MYELOBLASTIC LEUKEMIA; BLOOD; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; TRANSCRIPTION INITIATION;

CELL PROLIFERATION; CYTOKINES; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, LEUKEMIC; GRANZYMES; HEK293 CELLS; HUMANS; INTEGRIN BETA3; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, ACUTE; PROTEIN ISOFORMS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84903386491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098936     Document Type: Article

References (41)

1. Takada Y, Ye X, Simon S (2007) The integrins. Genome Biol 8: 215.
2. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
3. Tarone G, Hirsch E, Brancaccio M, De Acetis M, Barberis L, et al. (2000) Integrin function and regulation in development. Int J Dev Biol 44: 725-731.
4. Blencowe BJ (2006) Alternative splicing: new insights from global analyses. Cell 126: 37-47.
5. Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fassler R (2002) Integrins in invasive growth. J Clin Invest 109: 999-1006. (Pubitemid 34408573)
6. Jin R, Trikha M, Cai Y, Grignon D, Honn KV (2007) A naturally occurring truncated beta3 integrin in tumor cells: native anti-integrin involved in tumor cell motility. Cancer Biol Ther 6: 1559-1568. (Pubitemid 351590327)
7. Lonsdorf AS, Kramer BF, Fahrleitner M, Schonberger T, Gnerlich S, et al. (2012) Engagement of alphaIIbbeta3 (GPIIb/IIIa) with alphanubeta3 integrin mediates interaction of melanoma cells with platelets: a connection to hematogenous metastasis. J Biol Chem 287: 2168-2178.
8. Estey E, Dohner H (2006) Acute myeloid leukaemia. Lancet 368: 1894-1907. (Pubitemid 44794525)
9. Smits EL, Lee C, Hardwick N, Brooks S, Van Tendeloo VF, et al. (2011) Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia. Cancer Immunol Immunother 60: 757-769.
10. Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, et al. (2007) Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 19: 142-147. (Pubitemid 46204354)
11. Verheyden S, Demanet C (2008) NK cell receptors and their ligands in leukemia. Leukemia 22: 249-257. (Pubitemid 351250528)
12. Szczepanski MJ, Szajnik M, Welsh A, Foon KA, Whiteside TL, et al. (2010) Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors. Cancer Immunol Immunother 59: 73-79.
13. Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, et al. (2007) Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood 109: 323-330. (Pubitemid 46053073)
14. Vrbanus L, Sucic M, Markovic-Glamocak M, Ries S, Gjadrov-Kuvezdic K, et al. (2010) Apoptosis of leukemic cells: a case report. Coll Antropol 34: 705-711.
15. Whiteway A, Corbett T, Anderson R, Macdonald I, Prentice HG (2003) Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission. Br J Haematol 120: 442-451.
16. Barrett AJ, Le Blanc K (2010) Immunotherapy prospects for acute myeloid leukaemia. Clin Exp Immunol 161: 223-232.
17. Djaffar I, Chen YP, Creminon C, Maclouf J, Cieutat AM, et al. (1994) A new alternative transcript encodes a 60 kDa truncated form of integrin beta 3. Biochem J 300 (Pt 1): 69-74. (Pubitemid 24151018)
18. Allen DL, Abrahamsson S, Murphy MF, Roberts DJ (2012) Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin alpha(IIb)beta(3) (GPIIb/IIIa). J Immunol Methods 375: 166-175.
19. Skaik Y, Battermann A, Hiller O, Meyer O, Figueiredo C, et al. (2013) Development of a single-antigen magnetic bead assay (SAMBA) for the sensitive detection of HPA-1a alloantibodies using tag-engineered recombinant soluble beta3 integrin. J Immunol Methods 391: 72-80.
20. Jaimes Y, Figueiredo C, Blasczyk R (2010) Silencing the expression of platelet endothelial cell adhesion molecule-1 prevents allogeneic T-cell cytotoxicity. Transfusion 50: 1988-2000.
21. Geller MA, Knorr DA, Hermanson DA, Pribyl L, Bendzick L, et al. (2013) Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model. Cytotherapy 15: 1297-1306.
22. Kim HW, Kim JE, Hwang MH, Jeon YH, Lee SW, et al. (2013) Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells. PLoS One 8: e70194.
23. Pieper C, Marek JJ, Unterberg M, Schwerdtle T, Galla HJ (2014) Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in?vitro. Brain Res.
24. Pardo J, Balkow S, Anel A, Simon MM (2002) Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control. Eur J Immunol 32: 2881-2887.
25. Eisele G, Wolpert F, Decrey G, Weller M (2013) APO010, a synthetic hexameric CD95 ligand, induces death of human glioblastoma stem-like cells. Anticancer Res 33: 3563-3571.
26. Siena L, Pace E, Ferraro M, Di Sano C, Melis M, et al. (2014) Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing. Immunology 141: 242-255.
27. Kon S, Atakilit A, Sheppard D (2011) Short form of alpha9 promotes alpha9beta1 integrin-dependent cell adhesion by modulating the function of the full-length alpha9 subunit. Exp Cell Res 317: 1774-1784.
28. Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, et al. (2005) Activation of NK cell cytotoxicity. Mol Immunol 42: 501-510. (Pubitemid 39655961)
29. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9: 503-510. (Pubitemid 351560519)
30. Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20: 323-370. (Pubitemid 34293428)
31. Leong JW, Fehniger TA (2011) Human NK cells: SET to kill. Blood 117: 2297-2298.
32. Lion E, Willemen Y, Berneman ZN, Van Tendeloo VF, Smits EL (2012) Natural killer cell immune escape in acute myeloid leukemia. Leukemia 26: 2019-2026.
33. Orleans-Lindsay JK, Barber LD, Prentice HG, Lowdell MW (2001) Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function-implications for the adoptive immunotherapy of leukaemia. Clin Exp Immunol 126: 403-411. (Pubitemid 34008710)
34. Soiffer RJ (2008) Donor lymphocyte infusions for acute myeloid leukaemia. Best Pract Res Clin Haematol 21: 455-466.
35. Ruggeri L, Aversa F, Martelli MF, Velardi A (2006) Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol Rev 214: 202-218. (Pubitemid 44707912)
36. Cho D, Campana D (2009) Expansion and activation of natural killer cells for cancer immunotherapy. Korean J Lab Med 29: 89-96.
37. Koehl U, Sorensen J, Esser R, Zimmermann S, Gruttner HP, et al. (2004) IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation. Blood Cells Mol Dis 33: 261-266. (Pubitemid 39446496)
38. Guilloton F, Jean C, de Thonel A, Laurent G, Quillet-Mary A (2007) Granzyme B induction signalling pathway in acute myeloid leukemia cell lines stimulated by tumor necrosis factor alpha and Fas ligand. Cell Signal 19: 1132-1140. (Pubitemid 46561551)
39. Wang Z, Gu J, Nie W, Xu J, Huang G, et al. (2013) Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk. Tumour Biol.
40. Wang R, Jaw JJ, Stutzman NC, Zou Z, Sun PD (2012) Natural killer cell-produced IFN-gamma and TNF-alpha induce target cell cytolysis through upregulation of ICAM-1. J Leukoc Biol 91: 299-309.
41. Xu G, Zhang Y, Zhang L, Ren G, Shi Y (2008) Bone marrow stromal cells induce apoptosis of lymphoma cells in the presence of IFNgamma and TNF by producing nitric oxide. Biochem Biophys Res Commun 375: 666-670.